Details for New Drug Application (NDA): 085454
✉ Email this page to a colleague
NDA 085454 describes DELAXIN, which is a drug marketed by Ferndale Labs and is included in one NDA. Additional details are available on the DELAXIN profile page.
The generic ingredient in DELAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
The generic ingredient in DELAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
Summary for 085454
| Tradename: | DELAXIN |
| Applicant: | Ferndale Labs |
| Ingredient: | methocarbamol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085454
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
